Gene mutation in metabolism syndrome with hematologic tumor: A retrospective cohort study

Key Points

• Gene mutations are associated with worsening conditions in patients suffering from metabolic syndrome and hematologic tumors.
• The study highlights significant findings with a focus on metabolic pathways and genetic expression.
• Retrospective cohort design allows for analysis of patient records to explore underlying genetic correlations.
• Identifying gene mutations may inform future treatment strategies; further validation in larger cohorts is needed.